NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

US High Growth Tech Stocks To Watch December 2025

As the United States market navigates a period of volatility, with major indexes closing lower amid concerns over an AI bubble and looming economic reports, investors are keenly observing the tech sector's dynamics. In such a climate, identifying high-growth tech stocks involves looking for companies with strong fundamentals and resilience to market pressures.
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

3 Stocks Estimated To Be Trading At Discounts Of 23.8% To 35.3%

As the United States stock market grapples with concerns over an AI bubble and fluctuating major indexes, investors are keenly observing economic indicators like the upcoming jobs report to gauge future market directions. In this environment of uncertainty, identifying stocks that are potentially undervalued can offer opportunities for those looking to capitalize on price discrepancies; such stocks may be trading at significant discounts relative to their intrinsic value, providing a...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Three Insider-Favored Growth Companies To Watch

As the U.S. stock market grapples with pressures on AI stocks and anticipates key economic data releases, investors are keenly observing how these factors influence broader market trends. In such a volatile environment, growth companies with high insider ownership often stand out as they suggest confidence from those closest to the business, making them intriguing prospects for investors seeking stability amid uncertainty.
NasdaqGM:ARTV
NasdaqGM:ARTVBiotechs

Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders

As the year draws to a close, U.S. markets are experiencing volatility, with major indexes closing lower amid concerns about an AI bubble and looming economic reports. In such a climate, investors often look beyond the large-cap stocks dominating headlines to explore opportunities in lesser-known areas like penny stocks. While the term "penny stocks" may seem outdated, it continues to signify smaller or emerging companies that could offer significant value when backed by strong financials and...
NasdaqGS:JJSF
NasdaqGS:JJSFFood

Top Dividend Stocks To Consider In December 2025

As the U.S. stock market navigates a challenging landscape with AI stocks under pressure and economic data closely watched, investors are increasingly seeking stability amid volatility. In such an environment, dividend stocks can offer a reliable income stream, making them an attractive option for those looking to balance potential risks with steady returns.
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Roper Technologies (ROP): Has the Recent Share Price Slide Opened a Valuation Opportunity?

Roper Technologies (ROP) has been drifting lower this year, with shares down about 14% year to date even as revenue and net income keep growing at a steady high single digit pace. See our latest analysis for Roper Technologies. That slide has left Roper with a roughly 13.6% year to date share price decline and a weaker 1 year total shareholder return. This suggests investors are reassessing how much they will pay for its steady but unspectacular growth profile. If Roper’s softer momentum has...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is Incyte’s 2025 Surge Justified by Cash Flow Outlook and Oncology Pipeline Progress?

Wondering if Incyte is still a smart buy after its big run, or if most of the upside is already priced in? This breakdown will help you decide whether the current share price offers real value or just story driven momentum. Incyte's stock is up 39.8% over the past year and 39.6% year to date, even after a recent 6.8% slide over the last month and a modest 2.0% bump in the last week around the $97.03 level. This suggests investors may be reassessing both its growth potential and risk...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health Investments (CLOV): Is the Market Undervaluing Its Tentative Share Price Recovery?

Clover Health Investments (CLOV) has quietly shifted gears this year, with the stock up around 7% over the past month even as its past 3 months performance remains negative. See our latest analysis for Clover Health Investments. That recent 6.9% 1 month share price return sits against a weak year to date share price performance and a still negative 1 year total shareholder return, suggesting sentiment is tentatively improving but far from fully convinced. If Clover’s move has you rethinking...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Can Cognizant Still Offer Value After Recent 3.3% Weekly and 59.6% Three Year Gains?

If you have been wondering whether Cognizant Technology Solutions is still worth buying at around $83.63, you are not alone; this stock has quietly become a classic "is it still good value" candidate. The share price has climbed 3.3% over the last week, 15.2% in the past month, and 9.4% year to date, while longer term holders have seen gains of 59.6% over three years and 11.5% over five years. Recently, investors have been reacting to a steady drumbeat of strategy updates, major client wins,...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Does Zoom’s AI Expansion Justify Its 2025 Valuation After a 78.5% Five Year Slump?

If you are wondering whether Zoom Communications at around $87.91 is still a post pandemic fad or a quietly mispriced opportunity, this breakdown is for you if you are trying to figure out whether the current share price lines up with the company’s real value. Despite a brutal 5 year drawdown of about 78.5%, the stock has crept back into positive territory with a 7.8% gain year to date and a modest 3.9% rise over the last 12 months, which suggests sentiment may be slowly turning. Recently,...
NYSE:NEE
NYSE:NEEElectric Utilities

Does NextEra Energy Still Offer Upside After Its 2025 Renewables Expansion Push?

Wondering if NextEra Energy is still a smart buy at around $81 a share, or if the easy gains are already behind it? Let us unpack whether the current price leaves any real upside on the table. Over the last week the stock has edged up 2.1%, but it is still down 3.1% over the past month, even though it is up 13.6% year to date and 16.0% over the last year, and 23.7% over five years. This pattern hints at a steady long term compounding story rather than a speculative spike. Recent headlines...
NYSE:PBF
NYSE:PBFOil and Gas

PBF Energy (PBF): Revisiting Valuation After a Sharp Sell-Off and Strong Long-Term Returns

PBF Energy (PBF) shares have been under pressure recently, sliding over the past month and past 3 months, and that drawdown is making value focused investors recheck the long term story. See our latest analysis for PBF Energy. Zooming out, PBF Energy’s recent sell off, including a sharp 1 day share price return of minus 10.99 percent and a 30 day share price return of minus 31.67 percent, contrasts with a 5 year total shareholder return of 343.82 percent. This suggests long term investors...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD) Is Up 7.4% After Dividend Hike Despite EPS Miss And Director Sale

Royal Gold recently reported record third-quarter 2025 revenue but missed earnings-per-share expectations and at the same time announced a 6% increase in its annual dividend for 2026, to be paid quarterly from January 16, 2026. A director share sale of about US$109,145 and a higher dividend alongside an earnings miss give investors mixed signals about near-term profitability and capital returns. Next, we’ll examine how Royal Gold’s record revenue but weaker earnings reshape its investment...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

Nano Nuclear Energy (NNE): Assessing Valuation After New Microreactor Deals and FY 2025 Webcast Update Plans

NANO Nuclear Energy (NNE) has been drawing fresh attention after scheduling a Fiscal Year 2025 business update webcast and signing agreements to test its microreactors in real world data center and Texas facility settings. See our latest analysis for NANO Nuclear Energy. Those data center and Texas deployment plans seem to be shifting how investors are thinking about NANO Nuclear’s growth runway. The share price is at $32.31 after a 1 year to date share price return of 35.02 percent and a 1...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

Assessing SLM’s (SLM) Valuation After Analyst Downgrades Following Its Investor Forum

SLM (SLM) is back in focus after its recent Investor Forum prompted a wave of analyst revisions, with several firms trimming earnings forecasts and tempering their outlook on margins and operating costs. See our latest analysis for SLM. Those cautious revisions seem to be weighing on sentiment, with the share price at $26.84 and a slightly negative year to date share price return. However, the three and five year total shareholder returns of 75.9 percent and 141.0 percent suggest the longer...
NYSE:FRT
NYSE:FRTRetail REITs

Taking Another Look at Federal Realty (FRT) Valuation After Jefferies’ Upgrade and Recent Strategic Moves

Jefferies just upgraded Federal Realty Investment Trust (FRT) to Buy after the REIT ramped up its coastal footprint with acquisitions like Annapolis Town Center and Village Pointe, plus fresh board oversight from Joseph D. Fisher. See our latest analysis for Federal Realty Investment Trust. Even with this busy deal calendar, the stock’s 30 day share price return of just over 3 percent and slightly positive 3 year total shareholder return suggest momentum is only slowly rebuilding after a...
NasdaqGS:APA
NasdaqGS:APAOil and Gas

Assessing APA (APA)’s Valuation After Mixed Q3 Results, Stock Pop and Dividend Declaration

APA (APA) is back in focus after mixed Q3 results sent the stock up about 9% in a day, and the board followed up with a fresh 25 cent quarterly dividend declaration. See our latest analysis for APA. That post earnings pop came after a choppy spell, with the share price now at $23.96 and only a modest year to date share price return, but a stronger one year total shareholder return suggesting momentum is rebuilding as investors reassess APA’s cash generation and dividend support. If APA’s move...